🔎 Trials Near Me

Utama › Penyakit Buah Pinggang Kronik › Indiana

Kajian klinikal Penyakit Buah Pinggang Kronik di Indiana

7 kajian untuk Penyakit Buah Pinggang Kronik sedang mencari peserta di lokasi di Indiana.

Bandar di Indiana

Teks kajian rasmi (Bahasa Inggeris)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Indianapolis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06742723

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Indiana University, Indianapolis
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07107945

Effects of Replacing High Protein Foods in People With Chronic Kidney Disease

  • Purdue University, West Lafayette
Mengambil peserta
Umur 40 hingga 70 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07105670

Study of BHV-1400 in IgA Nephropathy

  • Site-012, Indianapolis
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07054684

Ferric Citrate and Chronic Kidney Disease in Children

  • Indiana U, Indianapolis
Mengambil pesertaFasa 2
Umur 6 hingga 18 · Semua jantina · Dikemas kini 17 Apr 2026 · NCT04741646

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • Lutheran Medical Group, Fort Wayne
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06001827

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.